SPTMay 7, 2026 at 8:05 PM UTCSoftware & Services

Sprout Social Reports Enterprise Growth and $50M Buyback, cRPO Question Lingers

Read source article

What happened

Sprout Social's Q1 2026 results showed approximated TTM subscription revenue contribution from customers with at least $30K in ARR grew 21% year-over-year, signaling continued enterprise traction, and the board authorized a $50 million share repurchase program. However, while the enterprise mix shift and capital return are positive signals, the release omitted cRPO growth—the key forward-looking metric that has been decelerating (from +21% YoY in Q1 2025 to +17% in Q3 2025). Without this data, investors cannot confirm that underlying demand is stabilizing, and the buyback may strain liquidity given $73 million in near-term purchase commitments. The market will need to assess whether the buyback is a confident use of cash or a distraction from fundamental weakness.

Implication

The $50M buyback signals management's view that stock is undervalued and provides a floor, but it consumes cash needed for commitments and NewsWhip integration. Investors should monitor the next quarterly disclosure for cRPO growth; if it stabilizes or re-accelerates, the buyback amplifies upside; if not, it becomes a distraction. The thesis now hinges on whether enterprise expansion (≥$30K ARR growth) translates into cRPO improvement. Maintain position size discipline until that evidence arrives.

Thesis delta

The prior master report framed the investment case around cRPO stabilization and margin protection amid CFO uncertainty. The new news confirms strong enterprise cohort growth (≥$30K ARR up 21% YoY) and adds a buyback, which modestly improves the risk-reward by signaling insider confidence and reducing share count. However, the absence of cRPO disclosure means the core demand deceleration narrative remains unresolved. The thesis now leans slightly more toward the base case (50% probability) but still requires the next earnings print to validate whether cRPO growth stops declining. The buyback does not change the bear case risk if cRPO drops to ≤14%.

Confidence

Moderate